Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.
Miyazaki T, Sohda M, Tanaka N, Suzuki S, Ieta K, Sakai M, Sano A, Yokobori T, Inose T, Nakajima M, Fukuchi M, Ojima H, Kato H, Kuwano H.
Miyazaki T, et al. Among authors: nakajima m.
Cancer Chemother Pharmacol. 2013 Apr;71(4):853-7. doi: 10.1007/s00280-013-2076-2. Epub 2013 Jan 10.
Cancer Chemother Pharmacol. 2013.
PMID: 23306309
Clinical Trial.